cystamine has been researched along with Prostatic Neoplasms in 3 studies
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Regarding prostate cancer aggressiveness, the 677TT genotype was associated with more than 50% decreased risk of high-grade prostate cancer (Gleason score >7) compared with the 677CC and 677CT genotypes (OR = 0." | 1.36 | Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and G1793A) gene and risk of prostate cancer: a case-control study. ( Safarinejad, MR; Safarinejad, S; Shafiei, N, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y | 1 |
| Xu, Z | 1 |
| Lu, T | 1 |
| Luo, J | 1 |
| Xue, H | 1 |
| Du, AW | 1 |
| Lu, H | 1 |
| Stenzel, M | 1 |
| Safarinejad, MR | 1 |
| Shafiei, N | 1 |
| Safarinejad, S | 1 |
3 other studies available for cystamine and Prostatic Neoplasms
| Article | Year |
|---|---|
Prostate-specific membrane antigen targeted, glutathione-sensitive nanoparticles loaded with docetaxel and enzalutamide for the delivery to prostate cancer.
Topics: Animals; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cystamine; Docetaxel; Glutathione; Hum | 2022 |
Stabilization of Paclitaxel-Conjugated Micelles by Cross-Linking with Cystamine Compromises the Antitumor Effects against Two- and Three-Dimensional Tumor Cellular Models.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cystamine; Drug Carriers; Humans; Male; Mice | 2016 |
Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and G1793A) gene and risk of prostate cancer: a case-control study.
Topics: Adult; Aged; Case-Control Studies; Cystamine; DNA; Folic Acid; Genetic Predisposition to Disease; Ge | 2010 |